These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 24289313)

  • 1. TGM3, a candidate tumor suppressor gene, contributes to human head and neck cancer.
    Wu X; Cao W; Wang X; Zhang J; Lv Z; Qin X; Wu Y; Chen W
    Mol Cancer; 2013 Dec; 12(1):151. PubMed ID: 24289313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA promoter hypermethylation contributes to down-regulation of galactocerebrosidase gene in lung and head and neck cancers.
    Peng J; Chen B; Shen Z; Deng H; Liu D; Xie X; Gan X; Xu X; Huang Z; Chen J
    Int J Clin Exp Pathol; 2015; 8(9):11042-50. PubMed ID: 26617822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting acid ceramidase sensitises head and neck cancer to cisplatin.
    Roh JL; Park JY; Kim EH; Jang HJ
    Eur J Cancer; 2016 Jan; 52():163-72. PubMed ID: 26687835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor suppressor activity and inactivation of galanin receptor type 2 by aberrant promoter methylation in head and neck cancer.
    Misawa Y; Misawa K; Kanazawa T; Uehara T; Endo S; Mochizuki D; Yamatodani T; Carey TE; Mineta H
    Cancer; 2014 Jan; 120(2):205-13. PubMed ID: 24122450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of neurofilament light polypeptide in head and neck cancer chemoresistance.
    Chen B; Chen J; House MG; Cullen KJ; Nephew KP; Guo Z
    Mol Cancer Res; 2012 Mar; 10(3):305-15. PubMed ID: 22246235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. X-linked FHL1 as a novel therapeutic target for head and neck squamous cell carcinoma.
    Cao W; Liu J; Xia R; Lin L; Wang X; Xiao M; Zhang C; Li J; Ji T; Chen W
    Oncotarget; 2016 Mar; 7(12):14537-50. PubMed ID: 26908444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells.
    Koutsimpelas D; Pongsapich W; Heinrich U; Mann S; Mann WJ; Brieger J
    Oncol Rep; 2012 Apr; 27(4):1135-41. PubMed ID: 22246327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA let-7a represses chemoresistance and tumourigenicity in head and neck cancer via stem-like properties ablation.
    Yu CC; Chen YW; Chiou GY; Tsai LL; Huang PI; Chang CY; Tseng LM; Chiou SH; Yen SH; Chou MY; Chu PY; Lo WL
    Oral Oncol; 2011 Mar; 47(3):202-10. PubMed ID: 21292542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical correlates of promoter hypermethylation of four target genes in head and neck cancer: a cooperative group correlative study.
    Roh JL; Wang XV; Manola J; Sidransky D; Forastiere AA; Koch WM
    Clin Cancer Res; 2013 May; 19(9):2528-40. PubMed ID: 23444219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic silencing of MAL, a putative tumor suppressor gene, can contribute to human epithelium cell carcinoma.
    Cao W; Zhang ZY; Xu Q; Sun Q; Yan M; Zhang J; Zhang P; Han ZG; Chen WT
    Mol Cancer; 2010 Nov; 9():296. PubMed ID: 21092172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transglutaminase 3 contributes to malignant transformation of oral leukoplakia to cancer.
    Wu X; Wang R; Jiao J; Li S; Yu J; Yin Z; Zhou L; Gong Z
    Int J Biochem Cell Biol; 2018 Nov; 104():34-42. PubMed ID: 30172723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage.
    Pannone G; Santoro A; Feola A; Bufo P; Papagerakis P; Lo Muzio L; Staibano S; Ionna F; Longo F; Franco R; Aquino G; Contaldo M; De Maria S; Serpico R; De Rosa A; Rubini C; Papagerakis S; Giovane A; Tombolini V; Giordano A; Caraglia M; Di Domenico M
    Curr Cancer Drug Targets; 2014; 14(2):115-27. PubMed ID: 24274398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. microRNA-107 functions as a candidate tumor-suppressor gene in head and neck squamous cell carcinoma by downregulation of protein kinase Cɛ.
    Datta J; Smith A; Lang JC; Islam M; Dutt D; Teknos TN; Pan Q
    Oncogene; 2012 Sep; 31(36):4045-53. PubMed ID: 22158047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LKB1 downregulation may be independent of promoter methylation or FOXO3 expression in head and neck cancer.
    Ekizoglu S; Dalay N; Karaman E; Akdeniz D; Ozaydin A; Buyru N
    Transl Res; 2013 Aug; 162(2):122-9. PubMed ID: 23810581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transglutaminase 3 protein modulates human esophageal cancer cell growth by targeting the NF-κB signaling pathway.
    Li W; Zhang Z; Zhao W; Han N
    Oncol Rep; 2016 Sep; 36(3):1723-30. PubMed ID: 27430245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DSG3 is overexpressed in head neck cancer and is a potential molecular target for inhibition of oncogenesis.
    Chen YJ; Chang JT; Lee L; Wang HM; Liao CT; Chiu CC; Chen PJ; Cheng AJ
    Oncogene; 2007 Jan; 26(3):467-76. PubMed ID: 16878157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SMYD2 overexpression is associated with tumor cell proliferation and a worse outcome in human papillomavirus-unrelated nonmultiple head and neck carcinomas.
    Ohtomo-Oda R; Komatsu S; Mori T; Sekine S; Hirajima S; Yoshimoto S; Kanai Y; Otsuji E; Ikeda E; Tsuda H
    Hum Pathol; 2016 Mar; 49():145-55. PubMed ID: 26826421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of gene promoter methylation in squamous cell cancer of the head and neck.
    Hasegawa M; Nelson HH; Peters E; Ringstrom E; Posner M; Kelsey KT
    Oncogene; 2002 Jun; 21(27):4231-6. PubMed ID: 12082610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-134 induces oncogenicity and metastasis in head and neck carcinoma through targeting WWOX gene.
    Liu CJ; Shen WG; Peng SY; Cheng HW; Kao SY; Lin SC; Chang KW
    Int J Cancer; 2014 Feb; 134(4):811-21. PubMed ID: 23824713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transglutaminase 3 regulates cutaneous squamous carcinoma differentiation and inhibits progression via PI3K-AKT signaling pathway-mediated Keratin 14 degradation.
    Zhou K; Wu C; Cheng W; Zhang B; Wei R; Cheng D; Li Y; Cao Y; Zhang W; Yao Z; Zhang X
    Cell Death Dis; 2024 Apr; 15(4):252. PubMed ID: 38589352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.